FDA Inspection 1244344 — Anoaneta Tomova

Anoaneta Tomova — FEI 3022575003

The FDA completed an inspection of Anoaneta Tomova on Jun 27, 2024 in Plovdiv. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 27, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Plovdiv (Bulgaria)

Additional details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.